Search results for: Precision Medicine
Filter search results
Biosimilars and HTA: Results of a Roundtable Discussion
9 April 2014
…an OHE literature review and ABPI’s position paper on biosimilar medicines. The published Briefing focuses primarily on discussion about recommendation five from the ABPI position paper: ‘Biosimilar medicines should be…
Measuring Health: a Practical Approach
7 January 1988
In Britain, the tax-payer pays the lion’s share of the national bill for medicines through the tax-supported NHS. There can be no doubt that the supplier of this long list…
Spotlight on OHE: EQ-5D-5L, Next Generation Sequencing, and MCDA
19 December 2014
…Medicine Symposium on the topic of next generation sequencing (NGS). The talk explained the advantages of NGS, and explored the areas in which it may add most value. Adrian acknowledged…
New Publication: Spillovers between Public and Private Sector Biomedical and Health Research
8 March 2016
…In the latest issue of BMC Medicine is an article assessing the complementarity between public and private sector R&D in the UK, co-authored by OHE’s Yan Feng and Jorge Mestre-Ferrandiz. …
OHE is pleased to appoint two Senior Visiting Fellows: Professor David Parkin and Professor Lou Garrison
5 October 2016
…development & accelerated access; Stratified medicine. Lou has co-authored numerous articles and consulting reports with OHE staff on topics around these three programmes. These include: Personalised Medicine: Economic Incentives for…
Incentives for New Drugs to Tackle Anti-Microbial Resistance
1 May 2017
…on new medicines are generally characterised as either “push” or “pull” programs. Resistance to antibiotics is growing, posing a major health risk in rich and poor countries. Additional ways of…
Recently Published: Reports on Policy Options for Formulary Development in Middle-income Countries and A Case Study from Mexico
4 January 2017
…and recommend methods that could help MICs efficiently and effectively identify medicines for formulary inclusion. The first report presents a framework for developing medicines formularies which combines macro-level decision making…
Public Health and Economic Implications of the United Kingdom Exiting the EU and the Single Market
12 December 2017
…Health Select Committee on ‘Brexit: the regulation of medicines, medical devices and substances of human origin’. Giving evidence to the committee today, Steve Bates, CEO of the BIA, will…
Valuing Health at the End of Life: A Review of Stated Preference Studies in the Social Sciences Literature
9 April 2018
Just published in Social Science & Medicine: a review of stated preferences examining the extent of support for an end of life premium. A source of debate in the health…